|Articles|August 10, 2004

Caprion Wins $13 Million Biodefense Research Contract to Study How Bacteria Subverts the Immune System

MONTREAL -- Caprion Pharmaceuticals Inc. has been awarded a $13.1 million contract by the U.S. National Institute of Allergy and Infectious Diseases (NIAID), a part of the National Institutes of Health, to carry out biodefense research. This award is the result of a highly competitive and international selection process.

 

Under the five-year contract, Caprion will study molecular events that enable bacteria to subvert the immune system. This work aims to define novel pathways and proteins that will provide a basis for the development of new immunotherapy targets, vaccines, and diagnostic candidates. Caprion will employ its quantitative protein profiling technologies to analyze pathogen and host proteins involved during Brucella infection. Brucella is a potential bioterrorism agent and is responsible for considerable global economic losses due to disease in cattle.

 

"The opportunity to work in this important area of medical research and to execute the innovative studies proposed to the NIAID," is exciting for Caprion, said Lloyd Segal, CEO at Caprion. "This project will further the biodefense research goals of the NIAID and enable Caprion to further develop its portfolio of infectious disease clinical programs." Caprion recently acquired a clinical program for the prevention of Hemolytic Uremic Syndrome (HUS) resulting from E. coli infection.

 

This research stems from studies carried out by Caprion in partnership with Dr. Michel Desjardins, Universite de Montreal, Department of Pathology and Cellular Biology. Desjardins will participate as a collaborating investigator. Desjardins is a leader in the study of intracellular pathogens and has contributed significantly to the understanding of the front line host defense systems.

 

"We are confident that this research will lead to new therapeutic strategies for blocking pathogenic mechanisms and promoting host immune responses and that these strategies will be valuable for treating a range of infectious diseases that affect millions of people worldwide." said Desjardins.

 

Source: Caprion Pharmaceuticals Inc.

  

 


Related to this article

Infection preventionists in full PPE with children in DRC.  (Image credit: author with AI)
Nearly 4 months into the DRC's Bundibugyo virus disease outbreak, some indicators suggest transmission may be slowing. But shifting hotspots, treatment-center capacity problems, community deaths, and incomplete surveillance data show why national case totals alone cannot determine whether containment has been achieved.
Health care workers from the US speaking with other health care workers in DRC.  (Image credit: author with AI)
Is the Ebola outbreak in the DRC getting better? The answer depends on which numbers you examine. Several important indicators are moving in the right direction, including slower case growth and a declining Rₜ. But major gaps remain in contact tracing, testing, community deaths, safe burial coverage, and treatment capacity in some of the hardest-hit areas. ICT takes a deeper look at the latest outbreak data and why the numbers suggest cautious optimism, not victory.
Dyan Troxell, MSN, RN, director of clinical education at HandCraft Linen Services; J.J. Odom, MBA, CHESP, CMIP, T-CHEST, university director of buildings and grounds for UConn Health and chair-elect of the AHE Board; and Jenna Rivers, MPH, CPH, CIC, manager of infection prevention and control at Moffitt Cancer Center in Tampa, Florida.
At AHE Exchange 2026, ICT spoke with experts representing commercial laundry services, EVS, and infection prevention about the systems behind a successful reusable linen program. They discuss linen quality, reject rates, unnecessary waste, frontline education, data, PAR levels, infection prevention oversight, and why strong relationships between health care facilities and their laundry providers matter.
A group of students raising their hands in class during a lecture  (Adobe Stock 292282454 by Mediteraneo
How do you celebrate an infection that never happened? That's one of the unusual challenges infection preventionists share with teachers. Both can spend their careers changing outcomes they may never see. Both educate people who don't always want to listen. Both are second-guessed. Both face burnout. And both must somehow keep remembering why they started.